https://en.wikipedia.org/wiki/Manage..._schizophrenia

Για βαρος λεει αυτο

Alpha-lipoic acid[75][76] Weight gain Well-tolerated 1 DB-RPCT 360 Offset antipsychotic drug-induced weight gain. Increased total antioxidant status. May also increase GSH:GSSH (reduced glutathione:oxidized glutathione) ratio.[77]

Για αρνητικα

D-serine Global (especially negative symptoms) Well-tolerated 4 DB-RPCTs 183 Affinity towards the glycine site on NMDA receptors. D,Souza 2013,[42] Heresco-Levy 2005,[43] Lane 2005,[44] Lane 2010,[45] Tsai 1999,[46] Weiser 2012[47]

N-acetylcysteine[48] Global (especially negative symptoms) Well-tolerated 3 DB-RPCTs 140 Cystine and glutathione prodrug.[49][50] Cystine increases intracellular glutamate levels via the glutamate-cystine anti porter.

Berk 2008,[51] Berk 2011,[52] Carmeli 2012,[53] Lavoie 2008[54]
Sarcosine Global (especially negative symptoms) Well-tolerated 3 DB-RPCTs 112 GlyT1 antagonist (i.e. glycine reuptake inhibitor). Also known as N-methylglycine. Lane 2005,[44] Lane 2006,[55] Lane 2008,[56] Lane 2010,[45] Tsai 2004[57]

Για γνωστικα

Galantamine Cognition Well-tolerated 5 DB-RPCTs (1 negative) 170 Robust nootropic
Rivastigmine Cognition Well-tolerated 3 DB-RPCTs (all 3 negative; 5 trials including cross-over trials; 4 negative) 93, 131 (including cross-over trials) Seems to be a weaker nootropic
Tropisetron†[61][62][63][64] Cognitive and negative symptoms Well-tolerated 3 DB-RPCTs 120 Agonist at α7 nAChRs; antagonist at 5-HT3. Expensive (>$20 AUD/tablet).